Dialysis Catheters Market to Reach Nearly $1 Billion by 2027

Solid growth is expected for the global dialysis catheters market over the next six years as kidney disorders become more prevalent in society.

A new study by Polaris Market Research forecasts the market to expand 4.8 percent annually, reaching $976.2 million in 2027. The market is expected to be driven by such notable factors as lifestyle changes resulting in kidney disorders, an aging population (globally) seeking more medical care, and a surge in independent dialysis care centers in the United States and Europe. According to Lancet statistics, in 2017, 1.2 million people worldwide died from chronic kidney disease (CKD). The global mortality rate from CKD stood at 41.5 percent from 2014 to 2017. Moreover, in 2017, total recorded cases of CKDs were 697.5 million at a prevalence rate of 9.1 percent. 
 
Dialysis catheters is basically used for exchange of blood to and from a dialysis machine and the patient under treatment. Catheters has two lumens viz. venous and arterial. Arterial lumen carries blood away from the heart and supplies to dialysis machine whereas venous lumen returns blood back to the heart from the machine. Flow rates are maintained at in between 200 to 500 ml/min. The common site for placing catheters is superior vena cava (SVC), by puncturing jugular vein present in the neck, towards chest. SVC can also be inserted through sub-clavian vein. 
 
Dialysis centers offer exclusive dialysis services for the treatment of various renal disorders. There are more than 16,800 dialysis centers that offer services in more than 161 countries. DaVita is one of the leading dialysis service providers with more than 2,500 dialysis centers globally, while Fresenius Medical Care has more than 2,200 dialysis centers.
 
Home based renal care has become a norm in the United States, in line with this in April 2020, the U.S. based renal care provider, Outset Medical, announced that it received U.S. Food and Drug Administration (FDA) approval for its home based Tablo hemodialysis system. The system is all in one dialysis care machine handling both dialysate production and water purification. Similarly, in February 2020, U.S. based startup CloudCath raised $12 million in funding for commercializing its device for home monitoring of dialysis.

Companies are introducing innovative catheters technology to reduce complications. In February 2020, Bluegrass Vascular Technologies received FDA approval for its new inside out catheters access system. This system would be boon for those who have obstructed veins.
  
Market participants such as Fresenius Medical Care, NIPRO Medical Corporation, DaVita, Medical Components Inc., NIKKISO Co. Ltd., B. Braun, Foshan Special Medical, Toray Medical, Jiangxi Sanxin Medtec, AngioDynamics Inc., Asahi Kasei Medical Co. Ltd., Baxter International, NxStage Medical Inc., Shenzhen Shunmei Medical Technology, Outset Medical Inc., and ALLMED MEDICAL Corp. are some of the key players operating in the concerned market.